Catalyst Repository | Immunome Inc. Common Stock

Immunome Inc. Common Stock

(NASDAQ:IMNM)

Description

Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.

IMNM Overview

None
Sector
Health Care
Industry
Major Pharmaceuticals

Previous Close
$7.1200
Previous Close Volume
148750